Search clinical trials for: AngioDefender
Total 2 results
-
Everist Genomics, IncCompletedCardiovascular DiseasesCanada
-
Everist Genomics, IncCompletedCardiovascular DiseasesUnited States, Canada
Sponsors and Collaborators
- Stepping Hill Hospital
- University of the French West Indies and French Guiana
- Contego Medical, Inc.
- Center for Interdisciplinary Applied Research in Health, Health School of the Setubal, Polytechnic Institute
- American University of Sharfah
- CAR-T (Shanghai) Cell Biotechnology Co., Ltd.
- Bank of Cyprus Oncology Center BOCOC
- Istituto Di Ricerche Farmacologiche Mario Negri
- Susana Ferrandis Martinez
- UZA
- University of Calabar Teaching Hospital
- United Cerebral Palsy-Central Arizona
- Institut des Neurosciences de Montpellier
- Liling Hospital of Traditional Chinese Medicine
- Centro Studi Psicoterapia Neo-Funzionale
- MEDA PHARMA SPA, a Viatris company
- Bateman Horne Center
- Sonal Foundation, India
- Kroken Nursing Home, Tromsø
- Ege University Medical School
- View Full List
Medical Conditions
- PCST-Brief
- Commotio Retinae
- Anal Cancer
- Iris Neoplasms
- Intensive Care Acquired Cognitive Impairment
- Glioblastoma or Malignant Glioma
- Personality Disorder, Borderline
- Peri-Implantitis and Systemic Inflammation
- Ampulla of Vater Adenocarcinoma
- Postpartum Mood Disorder
- Uterine Cyst
- Native Arteriovenous Fistula
- Thrombocytopenia in CKD
- Metabolic Features
- Lung Injury, Acute and Respiratory Distress Syndrome, Adult
- Intraparenchymal Hemorrhage
- Diurnal Enuresis
- Endomicroscopy
- Ototoxicity, Drug-Induced
- De Quervain's Disease
- View Full List
Drug Interventions
- Flibanserin
- Polypharmacy using FDA-approved products
- Supraclavicular Brachial Plexus Block with Dexmedetomidine
- Toripalimab
- PLX3397
- Combined PIPAC / IV chemotherapy treatment
- Ortho Cyclen
- 13C-GSK1322322 stable isotope powder
- ALN-KHK
- Idarubicin
- NOAC
- GDC-0853
- Fluticasone
- Levetiracetam
- TAP-144-SR(6M)
- CEUS or Contrast enhanced Ultrasound
- CA125 guided strategy
- Etoposide
- Acalabrutinib
- Ropivacaine 0.25%, 0.5 ml/kg
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Burundi
- Contract Research Organizations in Canada
- Contract Research Organizations in China
- Contract Research Organizations in Israel
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Liberia
- Contract Research Organizations in Oman
- Contract Research Organizations in Senegal
- Contract Research Organizations in Singapore
- Contract Research Organizations in Taiwan
- Contract Research Organizations in United Kingdom
- CRO list by country